A share price of Ascendis Pharma A/S ADR [ASND] is currently trading at $139.66, up 8.70%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ASND shares have gain 11.27% over the last week, with a monthly amount glided 1.91%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Ascendis Pharma A/S ADR [NASDAQ: ASND] stock has seen the most recent analyst activity on June 25, 2024, when TD Cowen upgraded its rating to a Buy and also boosted its price target to $175 from $156. Previously, Stifel started tracking the stock with Buy rating on May 31, 2024, and set its price target to $200. On December 20, 2023, Jefferies initiated with a Buy rating and assigned a price target of $150 on the stock. Oppenheimer downgraded its rating to a Perform. Morgan Stanley downgraded its rating to Equal-Weight for this stock on April 04, 2023, and downed its price target to $108. In a note dated April 03, 2023, Credit Suisse downgraded an Neutral rating on this stock.
Ascendis Pharma A/S ADR experienced fluctuations in its stock price throughout the past year between $85.29 and $161.00. Currently, Wall Street analysts expect the stock to reach $174.75 within the next 12 months. Ascendis Pharma A/S ADR [NASDAQ: ASND] shares were valued at $139.66 at the most recent close of the market. An investor can expect a potential return of 25.13% based on the average ASND price forecast.
Analyzing the ASND fundamentals
Trailing Twelve Months sales for Ascendis Pharma A/S ADR [NASDAQ:ASND] were 356.00M which represents 188.79% growth. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -1.1%, Pretax Profit Margin comes in at -1.5%, and Net Profit Margin reading is -1.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.63, Equity is 5.11 and Total Capital is -102.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -2.81.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 132.24 points at the first support level, and at 124.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 143.81, and for the 2nd resistance point, it is at 147.96.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ascendis Pharma A/S ADR [NASDAQ:ASND] is 0.83. Also, the Quick Ratio is 0.54, while the Cash Ratio stands at 0.4. Considering the valuation of this stock, the price to sales ratio is 22.21.
